News

The Joint United Nations Programme on HIV/Aids (UNAids) has released a report that highlights a significant funding crisis ...
Botswana has surpassed the UN's 95-95-95 goals on HIV. Researchers say that the country is on track to end the public health threat of AIDS by 2030.
Life and death in Botswana: How immigration status affected my HIV/AIDS patients As a doctor treating HIV/AIDS patients, I did what I could do, what I had to do — one life at a time ...
Nearly 36 percent of adults in Botswana are believed to have HIV, the virus that causes AIDS. Elizabeth Farnsworth reports on efforts to combat the virus in part two of a four-part series.
Over the past 23 years, Botswana has gone from having the highest HIV infection rate in the world, with a prevalence of 36% among adults, to an estimated 16% last year.The Centre of Excellence has ...
2003-11-08 04:00:00 PDT Tutume, Botswana-- The prevailing wisdom on fighting AIDS in Africa has been that if the money was available and countries built a solid treatment program offering free ...
In Botswana, Step to Cut AIDS Proves a Formula for Disaster. July 23, 2007. By ...
When it opened in 2003, the Botswana-Baylor Children’s Clinical Centre of Excellence (Botswana-Baylor Trust) was the first pediatric HIV clinic on the African continent. Two decades later, its impact ...
[This report does not necessarily reflect the views of the United Nations] DUKWI CAMP, 12 June (PlusNews) - Dukwi refugee camp sprawls for 20sq.km into the Botswana bush along the road between ...
A religious movement that has so often taken public stands has been unusually quiet since Trump gutted the program to combat ...
Over the past 23 years, Botswana has gone from having the highest HIV infection rate in the world, with a prevalence of 36% among adults, to an estimated 16% last year.The Centre of Excellence has ...
as the recipient for one of its earliest big international grants: $50-million over five years to treat and fight AIDS as part of an unusual alliance with the pharmaceutical giant Merck & Company. The ...